MRPL48 and hepatocellular carcinoma: In summary, the findings of this study provide insights into the clinical significance, potential functions, interactive network, and association of MRPL48 with immune infiltration in HCC, providing a novel prognostic biomarker for predicting the survival and targeting targeted treatment of HCC during its early stages.